- /
- Supported exchanges
- / US
- / ESLOY.PINK
Essilor International SA (ESLOY PINK) stock market data APIs
Essilor International SA Financial Data Overview
EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in North America, the Middle East, Africa, Europe, Latin America, and the Asia-Pacific. It offers lens, eyewear, contact lenses, reading glasses under the Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir, eyexpert, iWear, Humanware, Optifog, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native Eyewear and Bolon, and Foster Grant brands. The company also provides vision assessment, eye pathology diagnosis and treatment, finishing equipment, fitting parameter measurement, small tools, and consumables. In addition, it offers SPECTRALIS, a multimodal imaging platform for the diagnosis and treatment; ANTERION, a multi-disciplinary all-in-one anterior segment imaging solution for measurements; HEYEX 2, an image management and device integration platform; HEYEX EMR, an electronic medical record platform; digital surgical visualization platform; and high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand. Further, the company designs, develops, markets, and maintains lens edging and mounting instruments for opticians and prescription laboratories; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It sells its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and consumers through the network of brick and mortar retail network and its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Essilor International SA (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Essilor International SA data using free add-ons & libraries
Get Essilor International SA Fundamental Data
Essilor International SA Fundamental data includes:
- Net Revenue: 27 242 M
- EBITDA: 5 626 M
- Earnings Per Share: 2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-16
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Essilor International SA News
New
EssilorLuxottica (ENXTPA:EL): Assessing Valuation After Recent Share Price Rally
EssilorLuxottica Société anonyme (ENXTPA:EL) shares have delivered a steady climb, gaining 14% over the past month and outpacing broad market trends. Investors continue to watch the company’s perf...
GEHC vs. ESLOY: Which Stock Is the Better Value Option?
Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologies (GEHC) and EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two companies is the best ...
Alibaba Is Coming for Meta’s Smart Glasses and ChatGPT. The Stock Rises.
Alibaba stock was climbing after it said it was launching AI-powered smart glasses and a new chatbot. Continue Reading View Comments
Is Exact Sciences (EXAS) Outperforming Other Medical Stocks This Year?
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Exact Sciences (EXAS) one of those stocks right now? Let's take a closer look at ...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.